Enrico Domenici

Enrico Domenici is Full Professor at the Centre for Integrative Biology University of Trento, where he is leading the Neurogenomic Biomarkers Unit and coordinating the MSc in Quantitative and Computational Biology.  He also serves as President at The Microsoft Research – University of Trento Centre for Computational and Systems Biology (COSBI).

He has joined the University after 25 years of experience in Drug Discovery at GlaxoSmithKline and Roche, where he has led a number of drug discovery programs aimed at identifying novel targets and biomarkers by combining genetics, genomics and proteomics. During his scientific career, he has established a number of academia-industry collaborations and precompetitive consortia, and has authored 80+ scientific publications in international peer reviewed journals. He currently serves in advisory and scientific boards and is member of reviewing panels for European funding agencies.